Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (381)	9/8/1999 1:36:00 AM
From: Vector1	Read Replies (1) \| Respond to of 3044

<<don't you worry about the inmates (scientists) running the asylum >> Sounds like MLMN You are right though I would rather have a nosebleed MLMN than a CLTR gaping wound. I unloaded my entire position in the 60s. I have to learn how to be a momentum guy. They really know how to have fun. On TRMS I am intrigued by T-20. It has a novel mechanism of action and I read in a Robbi Stephens report today that the ICAAC abstract will involve a highly treated and refactory population. If they have good data with these patients they go on the FDA express line. The one AGPH traveled to glory and a WLA buyout. Can Roche be far behind. V1